首页> 外文期刊>Medicine. >Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention
【24h】

Factors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary intervention

机译:经皮冠状动脉介入治疗一年后中国急性冠脉综合征患者未达到低密度脂蛋白胆固醇目标的相关因素

获取原文
           

摘要

Reducing low-density lipoprotein cholesterol (LDL-C) to target ≤1.81 mmol/L is a common therapeutic goal after acute coronary syndrome (ACS). This study aimed to examine the factors associated with reaching or not this LDL-C target after 1 year of optimal statin therapy postpercutaneous coronary intervention (PCI). This was a retrospective study of 633 consecutive prospectively enrolled patients with ACS treated between January 2011 and December 2012 at the Beijing Hospital (China). All patients were treated with PCI and statins for 1 year. A multivariate analysis was carried out to identify the factors associated with reaching the LDL-C target of ≤1.81 mmol/L. The rate of unreached LDL-C goal after 1 year was 48%. Compared with those who achieved their LDL-C goal, patients not achieving their LDL-C goal showed a higher proportion of females (37.9% vs 28.7%, P < 0.001), higher LDL-C levels at admission (2.82 ± 0.75 vs 2.08 ± 0.70 mmol/L, P < 0.001), lower proportion of patients with a history of PCI (17.6% vs 24.8%, P = 0.03), and younger age (66.7 ± 10.6 vs 68.9 ± 10.1 years, P = 0.009). A multivariate analysis showed that lower LDL-C levels on admission were predictive of LDL-C goal achievement (odds ratio [OR] = 4.81; 95% confidence interval [CI]: 3.46–6.70; P < 0.001), together with older age (OR: 0.98; 95% CI: 0.96–0.997; P = 0.026), and male gender (OR: 0.64; 95% CI: 0.42–0.98; P = 0.040). Higher LDL-C levels at admission, younger age, and female gender were independently associated with not reaching the LDL-C target after 1 year of optimal statin therapy after PCI.
机译:将低密度脂蛋白胆固醇(LDL-C)降至目标值≤1.81mmol / L是急性冠脉综合征(ACS)后的常​​见治疗目标。这项研究的目的是检查经皮冠状动脉介入治疗(PCI)1年最佳他汀类药物治疗后,是否达到LDL-C目标的相关因素。这是一项对2011年1月至2012年12月间在北京医院(中国)接受治疗的633例ACS患者的回顾性研究。所有患者均接受PCI和他汀类药物治疗1年。进行多变量分析以鉴定与达到LDL-C目标≤1.81mmol / L有关的因素。一年后未达到LDL-C目标的比率为48%。与达到LDL-C目标的患者相比,未达到LDL-C目标的患者女性比例更高(37.9%对28.7%,P <0.001),入院时LDL-C水平较高(2.82±0.75对2.08) ±0.70 mmol / L,P <0.001),有PCI史的患者比例较低(17.6%vs 24.8%,P = 0.03),且年龄较小(66.7±10.6 vs 68.9±10.1岁,P = 0.009)。多元分析表明,入院时较低的LDL-C水平可预测达到LDL-C的目标(优势比[OR] = 4.81; 95%置信区间[CI]:3.46-6.70; P <0.001),以及年龄较大(OR:0.98; 95%CI:0.96-0.997; P = 0.026)和男性(OR:0.64; 95%CI:0.42-0.98; P = 0.040)。 PCI术后1年最佳他汀类药物治疗后,入院时较高的LDL-C水平,年龄和女性性别均与未达到LDL-C目标独立相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号